通元针法用于原发性高血压的临床研究

Abstract
Figure/Table
References (26)
Related Citation (11)

Download: PDF (624 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the efficacy and safety of Tongyuan needling technique in the treatment of essential hypertension. Methods Sixty cases of patients with essential hypertension treated in Department of Acupuncture and Moxibustion, Guangzhou Hospital of Traditional Chinese Medicine and the First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine from August 2015 to December 2017 were selected, and they were divided into observation group (30 cases) and control group (30 cases) by random number table method. The observation group was treated with Tongyuan needling technique, twice a week, for 8 weeks; the control group was treated with oral Nifedipine Controlled Released Tablets 30 mg, once a day, for 8 weeks. The clinical blood pressure and adverse reactions of the two groups were recorded. Results The systolic and diastolic blood pressures of the two groups were all significantly lower than those before treatment (P ＜ 0.05), but the systolic and diastolic blood pressures after treatment between the two groups had no statistically significant difference (P ＞ 0.05). The total effective rate of observation group and control group was 96.67% and 86.67% respectively, with no statistically significant difference between the two groups (P ＞ 0.05). The incidence of adverse reactions in the observation group and the control group was 3.3% and 23.33% respectively, there was a significant difference (P ＜ 0.05). Conclusion Tongyuan needling technique in the treatment of essential hypertension is effective, with few adverse reactions and high security.

Key words： Tongyuan needling technique Essential hypertension Nifedipine Controlled Released Tablets Adverse reactions

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHENG Jie1 LAI Xinsheng2 LIN Shaozhen1 WU Peilong2

Cite this article:

ZHENG Jie1 LAI Xinsheng2 LIN Shaozhen1 WU Peilong2. Clinical study of “Tongyuan needling technique” for essential hypertension[J]. 中国医药导报, 2018, 15(15): 135-138.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2018/V15/I15/135

[1] 陆再英，钟南山，谢毅，等.内科学[M].北京：人民卫生出版社，2008：251-264.
[2] 刘力生.中国高血压防治指南2010年修订版[J].中华心血管病杂志，2011，39（7）：579-616.
[3] 周仲英.中医内科学[M].北京：中国中医药出版社，2003：297-304.
[4] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京：中国中医药科技出版社，2002：73-77.
[5] 陈伟伟，高润霖，刘力生，等.《中国心血管病报告2016》概要[J].中国循环杂志，2017，32（6）：521-530.
[6] 郭丽花，胡如英，龚巍巍，等.脑卒中危险因素研究进展[J].中国老年学杂志，2017，37（17）：4413-4416.
[7] Guo J，Zhu YC，Chen YP，et al. The dynamics of hypertension prevalence，awareness，treatment，control and associated factors in Chinese adults：results from CHNS 1991-2011 [J]. J Hypertens，2015，33：1688-1696.
[8] 陈青山，王继业，田浩，等.高血压患者动脉弹性功能与靶器官损害的临床研究[J].华南国防医学杂志，2015，29（10）：761-763.
[9] 张屏，周晓敏，刘丹，等.南方青年人中原发性高血压与肾动脉狭窄的比较研究[J].中国分子心脏病学杂志，2017， 17（5）：2229-2231.
[10] 帅凤俊，王道成，薛刚，等.中西医结合治疗高血压早期肾损害伴颈动脉粥样硬化的临床研究[J].江苏中医药，2017，49（11）：28-30.
[11] 阮承超，高平进.免疫与炎症参与高血压发生发展的机制探讨[J].中华高血压杂志，2017，25（4）：319-321.
[12] 谭元生，黄露.高血压病中医证型与证素分布规律的文献研究[J].中华中医药学刊，2015，33（11）：2570-2573.
[13] 沙中坚，吴江.各类降压药的副作用及正确应用[J].中国误诊学杂志，2005，5（14）：2782-2783.
[14] 郑舒月，牛晓雨，成西，等.刘燕池教授从“五脏同调”治疗高血压病的临证经验[J].环球中医药，2016，9（10）：1256-1258.
[15] 陈爱霞，陆妍，孟祥刚，等.“活血散风、疏肝健脾”针刺法治疗高血压近况[J].西部中医药，2017，30（1）：131-134.
[16] 张兵倩，王明.艾司西酞普与非洛地平联合治疗高血压合并抑郁的效果观察[J].中国现代医生，2016，54（35）：93-96.
[17] Neutel JM，Smith DH，Weber MA，et al. Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension：the systolic Evaluation of Lotrel Efficacy and Comparative Therapies（SELECT）study [J]. J Clin Hypertens，2005，7（11）：641-646.
[18] Webb AJ，Fischer U，Mehta Z，et al. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke：a systematic review and meta-analysis [J]. Lancet，2010，375（9718）：906-915.
[19] 高芳，陈彤，石辉，等.中西医结合治疗老年单纯收缩期高血压的多中心随机双盲对照临床研究[J].中国现代医生，2016，54（11）：125-127.
[20] 万斌，孙丽薇，刘蓉，等.电针对2型糖尿病合并肾性高血压大鼠模型的疗效[J].中国实验动物学报，2016，24（6）：622-627.
[21] 杨路，吴春晓，陈莹[J].针刺手三阴经原穴对高、低血压模型大鼠经穴特异性的影响[J].广州中医药大学学报，2016，33（3）：334-338.
[22] 陈震益，赖新生.赖新生“通元针法”之立法依据浅析[J].中华中医药杂志，2016，31（8）：2974-2976.
[23] 李焕敏，李春光.基质金属蛋白酶9及其组织型抑制因子1在高血压大鼠血液及组织中的变化[J].中国实验动物学报，2017，25（2）：138-145.
[24] 张春红，邢瀚，乔波.石学敏治疗高血压病经验[J].中医杂志，2011，52（20）：1729-1730.
[25] 马素起.涌泉穴贴敷治疗肝阳上亢型高血压病80例[J].中华高血压杂志，2015，30（5）：1028-1029.
[26] Longhurst JC，Tjenalooi SC. Evidence-based blood pressure reducing actions of electroacupuncture：mechanisms and clinical application [J]. Acta Physiologica Sinica，2017， 69（5）：587-597.